“The downgrade reflects a multiyear trend of negative operating performance with accelerated losses in fiscal 2015,” said S&P analyst Margaret McNamara. “This was due in part to one-time adjustments and persistent and ongoing operating losses at the employed physician entity, which led to a covenant violation.”
The outlook is negative, reflecting continued pressure on PMC’s operational performance in spite of turnaround efforts.
More articles on healthcare finance:
La. begins enrolling 375k people into Medicaid, first state to expand registry through food stamp collections information
Most Americans cannot afford long-term care, survey finds
UPMC enters 3rd partnership in China
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
